Journals / Türk Jinekoloji ve Obstetrik Derneği Dergisi / 2010 / Cilt: 7 - Sayı: 3

The effect of screening tests to maternal anxiety levels on pregnant women

Gebelikte uygulanan taramatestlerinin anne anksiyetesine olan etkisi

Pages
206–211
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When the pregnant women, by taking into regard their groups as to education and age, were analyzed with respect to their anxiety levels, no statistical differences were observed among the groups.± When a question such as “What would you do if your prospective baby has been diagnosed as having a Down Syndrome” was posed 181 patients (60,3%) answered that they have not yet given any decision in this regard.When we analyzed the pregnants with respect to their educational levels, we recorded a significant statistical difference among the university graduates group and other groups. (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed at measuring levels of knowledge of pregnant about Down Syndrome, triple screening test, amniocentesis, and other tests performed during pregnancy their anxiety.
📊
Key Findings & Data:Material and Method: Our study includes 300 pregnant women between gestational weeks 16 and 20 and 35 gynecologists that we applied to their opinions.
💡
Conclusion & Impact:When the pregnant women, by taking into regard their groups as to education and age, were analyzed with respect to their anxiety levels, no statistical differences were observed among the groups.± When a question such as “What would you do if your prospective baby has been diagnosed as having a Down Syndrome” was posed 181 patients (60,3%) answered that they have not yet given any decision in this regard.When we analyzed the pregnants with respect to their educational levels, we recorded a significant statistical difference among the university graduates group and other groups. (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: We aimed at measuring levels of knowledge of pregnant about Down Syndrome, triple screening test, amniocentesis, and other tests performed during pregnancy their anxiety. Material and Method: Our study includes 300 pregnant women between gestational weeks 16 and 20 and 35 gynecologists that we applied to their opinions. STAI anxiety test measuring conditional anxiety was performed. Questions related to the levels of information of the pregnant women about Down syndrome, screening tests and amniocentesis and their communication with physicians. Attitude of physicians about the screening tests were questioned. Findings: The average age of patients was 28±5 and of them, a group comprising 37,3% was primipara while the other group comprising 62,7% had been multipara. When the pregnant women, by taking into regard their groups as to education and age, were analyzed with respect to their anxiety levels, no statistical differences were observed among the groups.± When a question such as “What would you do if your prospective baby has been diagnosed as having a Down Syndrome” was posed 181 patients (60,3%) answered that they have not yet given any decision in this regard.When we analyzed the pregnants with respect to their educational levels, we recorded a significant statistical difference among the university graduates group and other groups. (p

Özet

Amaç: Bu çalışma gebelikte uygulanan tarama testlerinin hasta anksiyetesi üzerine olan etkisini araştırmak amacıyla planlanmıştır. Gereç -Yöntem: Çalışmamız 16- 20. haftalar arası 300 gebeyi ve görüşlerine başvurduğumuz 35 kadın hastalıkları ve doğum uzmanını kapsadı. Durumsal anksiyeteyi ölçen STAI anksiyete testi tüm olgulara uygulandı. Gebelerin Down sendromu, tarama testleri ve amniosentez hakkında bilgi düzeyleri, hekimle olan iletişimleri için anket formuyla sorular soruldu. Hekimlerin gebelerin tarama testleri ile olan tutumları yine anket ile sorgulandı. Veriler hasta, hekim sayısı ve yüzde değer olarak ifade edildi. Değerlendirmede nonparametrik ki kare testi uygulandı. Gruplar arası farklılığın değerlendirilmesinde ise çok gözlü düzeyde ki kare testi, Zafson Programı ile kullanıldı. P değeri 0.05’in altında olan değerler istatistiksel olarak anlamlı kabul edildi. Bulgular: Hastaların ortalama yaşı 28±5 di. %37,3’ü primipar, %62,7’si ise multipardı. Paritelerine göre değerlendirildiğinde ise primipar hastaların multipar hastalardan daha fazla oranda tarama testleri hakkında bilgi sahibi olduğu teste verdikleri cevaplardan görüldü. (p

🔖

Cite This Article

ÇELİK, H., TOSUN, M., MALATYALIOĞLU, E., ÇETİNKAYA, M. B., BILDIRCIN, F. D., KÖKCÜ, A., ALPER, T., BİLGİN, S. (2022). The effect of screening tests to maternal anxiety levels on pregnant women. Türk Jinekoloji ve Obstetrik Derneği Dergisi, Cilt: 7 - Sayı: 3, 206–211. https://ajindex.com/articles/631649

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Lejeune J, Gauthier M, Turpin R. Les chromosomes humains en culture des tissues. Comptes Rentus de L'Académie des Sciences 1959; 248: 602- 3
  2. Ergin T. Ikinci trimester fetal anomali tarama testleri. In: Çiçek MN. eds. Kadın Hastalıkları Ve Doğum Bilgisi. Ankara: Güneş Kitabevi; 2006; 406- 8
  3. Berkman S. Has R. Doğum Bilgileri. In: Yüksel A. (eds), Düşük Riskli Gebelerde Antenatal Tarama Testleri. istanbul: Nobel Tıp Kitapevleri; 2004; 29- 33
  4. Mulvey S, Wallace E.M. Women’s knowledge of and attitudes to first and second trimester screening for Down’s syndrome. BJOG October 2000; Vol107, pp: 1302- 5
  5. Kleinveld JH, Timmermans DR, de Smit DJ, Adér HJ, van der Wal G, ten Kate LP. Does prenatal screening influence anxiety levels of pregnant women? A longitudinal randomised controlled trial. Prenatal Diagn. 2006 Apr; 26(4): 354- 61
  6. Kleinveld JH, Timmermans DR, van den Berg M, van Eijk JT, Ten Kate LP. Does offering and performing prenatal screening influence women's attachment to their unborn child? A longitudinal randomized controlled trial. Prenatal Diagn. 2007 Aug; 27(8): 757- 64
  7. Müller MA, Bleker OP, Bonsel GJ, Bilardo CM. Nuchal translucency screening and anxiety levels in pregnancy and puerperium. Ultrasound Obstet Gynecol. 2006 Apr; 27(4): 357- 61
  8. Weinans MJ, Huijssoon AM, Tymstra T, et al. How women deal with the results of serum screening for Down syndrome in the second trimester of pregnancy. Prenatal Diagn 2000; 20: 705- 8
  9. Gekas J, Gondry J, Mazur S, et al. Informed consent to serum screening for Down syndrome: are women given adequate information? Prenatal Diagn 1999; 19: 1- 7
  10. Michie S, Smith D, Marteau TM. Prenatal tests: How are women deciding? Prenatal Diagn 1999; 19: 743- 8
  11. Süreksiz Durumluk-Sürekli Kaygı Envanteri Elkitabı, istanbul: Boğaziçi Üniversitesi Yayımları; 1985
  12. Marteau TM, Cook R, Kidd J, et al. The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenatal Diagn 1992; 12: 205- 14
  13. Graaf I. M., Tijmstra T, Bleker O. P. Womens’ preference in Down syndrome screening. Prenatal Diagn 2002; 22: 624-9.